MDAngle

• CMSC 2024: Optimizing Multiple Sclerosis Treatment   Dr Annalisa Morgan discusses the implications of new data, emphasizing the importance of early high-efficacy therapy in new-onset highly inflammatory relapsing-remitting MS.
  Medscape, June 28, 2024
• ASCO 2024: Navigating New Data in Early Breast Cancer   Dr Avan J. Armaghani reflects on findings from ASCO on adjuvant therapies in early breast cancer, highlighting clinical dilemmas and future research directions.
  Medscape, June 25, 2024
• ASCO 2024: New Data's Impact on mBC Treatment Strategies   Dr Kevin Kalinsky considers how research presented at ASCO 2024 underscores the efficacy of trastuzumab deruxtecan in early treatment for certain types of breast cancer and supports the use of fulvestrant plus abemaciclib as a second-line therapy, offering hope for improved outcomes in patients with hormone receptor–positive breast cancer.
  Medscape, June 25, 2024
• ASCO 2024: The Effect of New Data on Prostate Cancer Care   Dr Sandy Srinivas reflects on her patients who may benefit from the results of the PSMAfore trial.
  Medscape, June 25, 2024
• ASCO 2024: Clinical Implications of New CML Data   Dr Cortes discusses clinical scenarios where he would apply data from the ASC4FIRST trial on asciminib in frontline CML treatment.
  Medscape, June 25, 2024
• ASCO 2024: Four Key Clinical Scenarios in Advanced NSCLC   Dr Tejas Patil highlights how pivotal data presented at ASCO will reshape treatment strategies for advanced non–small cell lung cancer.
  Medscape, June 25, 2024
• Insights Into MS Care Through the Lens of CMSC 2024   Dr Carrie Hersh discusses how CMSC emphasized its commitment to advancing patient care and addressing systemic challenges within the MS community.
  Medscape, June 21, 2024
• How Data From ATS 2024 Will Affect COPD Patient Care   Dr Stephanie A. Christenson shares insights from the latest COPD research presented at ATS 2024.
  Medscape, June 12, 2024
• ASCO 2024: Key Takeaways on Therapeutic Advancements in CML   Jorge E. Cortes, MD, highlights results for asciminib as a first-line therapy, and offers insights from long-term studies on ponatinib and bosutinib.
  Medscape, June 10, 2024
• ASCO 2024: Two Key Highlights in Metastatic Breast Cancer   Dr Kevin Kalinsky shares insights on two clinically impactful studies: DESTINY-Breast06 and postMONARCH.
  Medscape, June 10, 2024
• ASCO 2024: Practice-Changing Data in Advanced NSCLC   Tejas Patil, MD summarizes ASCO's impactful updates, highlighting the LAURA, CROWN, and PALOMA-3 studies, among others.
  Medscape, June 10, 2024
• ASCO 2024: Two Key Insights on New Early Breast Cancer Data   Dr Avan J. Armaghani highlights trial results regarding the role of adjuvant endocrine therapy.
  Medscape, June 07, 2024
• Key Insights on New Prostate Cancer Data From ASCO 2024   Dr Sandy Srinivas highlights new data on treatment efficacy, negative trial outcomes, and notable quality-of-life improvements for patients.
  Medscape, June 07, 2024
• Highlights and Insights From CMSC 2024   Annalisa Morgan, MD, summarizes presentations at CMSC 2024, emphasizing a shift towards innovative MS treatments, especially early high-efficacy therapy.
  Medscape, June 05, 2024
• ATS 2024: Advancing Therapeutic Options for COPD   Dr Stephanie A Christenson highlights promising new therapeutic developments in COPD, signaling potential advancements in patient care.
  Medscape, May 28, 2024
• CMSC 2024: Optimizing Multiple Sclerosis Care   Dr Annalisa Morgan previews discussions ranging from optimizing patient care pathways to exploring new therapies and addressing treatment dilemmas.
  Medscape, May 24, 2024
• AUA 2024: Prostate Cancer Treatment and Testing Updates   Dr Mohammad Mahmoud discusses key findings from AUA 2024 that will affect his patients with advanced prostate cancer.
  Medscape, May 23, 2024
• Conference MDAngle: ASCO 2024 – Early Breast Cancer Dr Avan J. Armaghani provides highlights from ASCO 2024, including anticipated presentations, quick takeaways, and insights into how the presented research will affect her patients.
  Medscape, June 20, 2024
• ASCO 2024: Addressing Unmet Needs in Early Breast Cancer   Dr Avan J. Armaghani previews ASCO updates on residual triple-negative breast cancer and ctDNA's clinical role in early breast cancer.
  Medscape, May 23, 2024
• Conference MDAngle: ASCO 2024 Metastatic Breast Cancer Dr Kevin Kalinsky provides highlights from ASCO 2024, including anticipated presentations, quick takeaways, and insights into how the presented research will affect patients.
  Medscape, June 19, 2024